Market LIVE
Published markets; coverage varies by country
Product profile · United States

JASCAYD

 ·  Patent Litigation & Settlement History ↓

IngredientNERANDOMILAST
Application typeNDA
Application218764
Product001
Dosage formTABLET
RouteORAL
Strength9MG
Approval date2025-10-07
Marketing statusPrescription
Status event—
ApplicantBOEHRINGER INGELHEIM
Product source

Current GenericRadar decision

Year2032
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS
Anchor date2032-08-23
Patent anchor2032-08-23
Exclusivity anchor2030-10-07
Protection date2038-10-22
First Final ANDA—
Status event—

US8609670 controls 2032-08-23. IPF ODE ending 2032-10-07 does not cover PPF; full NCE ends 2030-10-07. IPF-specific and combination tails remain.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
87540732029-11-26DS/DP/U U-4298———
———
86096702032-08-23DS ————
———
98029542034-02-19U U-4298———
———
114066382038-10-22U U-4373———
———
114066382038-10-22U U-4297———
———
118132662038-10-22U U-4292———
———
118132662038-10-22U U-4372———
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
I-979—2028-12-19————Source
NCE—2030-10-07————Source
ODE-546—2032-10-07————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
FINAL_REVIEW—ANCHOR_AND_TAILUS8609670 controls 2032-08-23. IPF ODE ending 2032-10-07 does not cover PPF; full NCE ends 2030-10-07. IPF-specific and combination tails remain.Source
Decision history
CurrentYearStatusReviewAnchorJudged
Y2032DEEP_REVIEWFINAL2032-08-232026-10-17 06:56:57
N2032DEEP_REVIEWFINAL2032-10-072026-10-14 18:32:45
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.